WHO世界卫生组织：2025年疟疾儿童药物优化会议报告（英文版）

This report provides a synthesis of the outcomes of the first paediatric drug optimization exercise that was held for Malaria. The PADO for malaria meeting brought together academic researchers, clinical experts, implementing partners and other key stakeholders involved in research and development to reach consensus on the first ever PADO lists for malaria. These contain three key antimalarial agents to be developed in the short term (PADO priority list) and to be monitored in the longer term